EN DE
STOCK COMPARISON

Seers Technology vs Abbott Laboratories: Fair Value & Quality

Both stocks run through our valuation models. Here is how Seers Technology (458870) and Abbott Laboratories (ABT) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Seers Technology trades at KRW 23,000 versus a fair value of KRW 5,932 (-74%), while Abbott Laboratories trades at $108 versus $74.79 (-31%).
Seers Technology
458870.KQ · KRW · Healthcare
-74%
upside to fair value
overvalued
PriceKRW 23,000
Fair ValueKRW 5,932
Quality60/100
Abbott Laboratories
ABT · USD · Health Care
-31%
upside to fair value
overvalued
Price$108
Fair Value$74.79
Quality67/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Seers TechnologyAbbott Laboratories
Valuation
P/E (TTM)27.7×
0.01×P/S (TTM)3.89×
P/B3.36×
EV/EBITDA15.1×
PEG1.47×
Profitability
40%Net margin14%
43%Operating margin13%
80%Return on equity12%
25%Return on assets6%
Growth
700%Revenue growth (YoY)8%
247.0%Avg. growth/yr (3Y)0.5%
Avg. growth/yr (5Y)5.1%
Balance & size
Debt / equity0.19×
$766MMarket cap$175B
expensiveGrowth qualityhealthy

Seers Technology leads: 7 to 0 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Seers Technologyof which business quality 58 · market factors 46 Abbott Laboratoriesof which business quality 66 · market factors 51
ProfitabilityMargins and returns on capital today
93
50
Quality GrowthAre margins and returns improving?
100
47
CashflowEarnings quality: real cash, not paper profit
12
71
Fin. StrengthBalance sheet, leverage, solvency risk
93
80
InvestmentDisciplined investing over empire-building
31
65
Low VolatilityCalm price path (market factor)
50
83
MomentumPrice trend over the last 3–12 months (market factor)
33
40
52W MomentumDistance to the 52-week high (market factor)
62
33
Net IssuanceBuybacks instead of dilution
0
84

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Seers Technology

DCF ModelsKRW 7,776
Earnings-BasedKRW 14,796
MultiplesKRW 4,886
Asset-BasedKRW 696
Growth DCFKRW 710
Economic ProfitKRW 6,231
Growth EarningsKRW 19,065

23 of 23 models see the stock below the current price.

Abbott Laboratories

DCF Models$73.01
Earnings-Based$29.42
Dividend Discount$39.73
Multiples$70.72
Asset-Based$20.05
Growth DCF$67.02
Economic Profit$37.49
Growth Earnings$70.25

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Seers Technology
Bear KRW 3,830Fair Value KRW 5,932Bull KRW 8,636
KRW 23,000 = current price (white tick)
Abbott Laboratories
Bear $51.84Fair Value $74.79Bull $94.43
$108 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Seers Technology · Healthcare

Quality score60 · above median
Fair value upside-74% · bottom 25%

Abbott Laboratories · Health Care

Quality score67 · Top 25%
Fair value upside-31% · below median

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Seers Technology trades at KRW 23,000 versus a fair value of KRW 5,932 (-74%), while Abbott Laboratories trades at $108 versus $74.79 (-31%).

Abbott Laboratories has the higher quality score (67/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.